tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Monopar Therapeutics announces inclusion in Russell 3000, Russell 2000
PremiumThe FlyMonopar Therapeutics announces inclusion in Russell 3000, Russell 2000
2M ago
Monopar Therapeutics reports Q1 EPS (38c), consensus (57c)
Premium
The Fly
Monopar Therapeutics reports Q1 EPS (38c), consensus (57c)
3M ago
Monopar Therapeutics Highlights ALXN1840 Data at EASL 2025
Premium
Company Announcements
Monopar Therapeutics Highlights ALXN1840 Data at EASL 2025
3M ago
Monopar Therapeutics sees cash runway through December 31, 2026
PremiumThe FlyMonopar Therapeutics sees cash runway through December 31, 2026
4M ago
Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year
Premium
The Fly
Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year
4M ago
Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
Premium
Ratings
Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
4M ago
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
PremiumThe FlyMonopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
6M ago
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
Premium
The Fly
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
7M ago
Monopar Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Monopar Therapeutics initiated with an Overweight at Piper Sandler
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100